Latest Articles

Publication Date
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post

Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post

Published: June 3, 2026, 2:49 p.m.
Robin Quivers Announces Remission Following Endometrial Cancer Battle - sekbernews.id

Robin Quivers Announces Remission Following Endometrial Cancer Battle sekbernews.id

Published: June 3, 2026, 2:32 p.m.
Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle - HarianBasis.co

Robin Quivers Announces Remission Following Extended Endometrial Cancer Battle HarianBasis.co

Published: June 3, 2026, 2:31 p.m.
Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detection - Nature

Optical coherence tomography enables optical biopsy of endometrial tissue for early cancer detection Nature

Published: June 3, 2026, 2:27 p.m.
Ibuprofen and endometrial cancer: An observational study finds a positive association. - unicaradio.it

Ibuprofen and endometrial cancer: An observational study finds a positive association. unicaradio.it

Published: June 3, 2026, 8:48 a.m.
NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer - Oncodaily

NRG-GY018 at ASCO 2026: Pembrolizumab Plus Chemotherapy Sustains Overall Survival Benefit in Advanced Endometrial Cancer Oncodaily

Published: June 3, 2026, 3:15 a.m.
Sacituzumab govitecan shows encouraging results for aggressive endometrial cancer - MSN

Sacituzumab govitecan shows encouraging results for aggressive endometrial cancer MSN

Published: June 3, 2026, 12:54 a.m.
MGST3 Promotes Endometriosis Progression by Suppressing Ferroptosis.

Endometriosis (EMs) is characterized by dysregulated persistence and enhanced invasiveness of ectopic endometrial cells. Current treatment strategies remain limited by high recurrence rates and considerable adverse effects. Although iron overload …

Published: June 3, 2026, midnight
GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity - Nature

GOT1 promotes endometrial cancer progression by regulating ferroptosis through the STAT3-GPX4 axis and attenuating medroxyprogesterone acetate sensitivity Nature

Published: June 2, 2026, 3:03 p.m.
Raising awareness for ovarian, endometrial cancers | 11 TV Hill - WBAL-TV

Raising awareness for ovarian, endometrial cancers | 11 TV Hill WBAL-TV

Published: June 2, 2026, 1:07 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!